Herein, we investigated the regulation of STAT3 activation and the therapeutic effects of Icaritin, a prenyl flavonoid derivative from Epimedium Genus, in renal cell carcinoma (RCC). The gene discussed is STAT3; the disease is hereditary clear cell renal cell carcinoma.